Urinary crystal surface binding substances on calcium oxalate crystals
- PMID: 2100413
- DOI: 10.1007/BF00297370
Urinary crystal surface binding substances on calcium oxalate crystals
Abstract
In order to study the effect of urinary crystal surface binding substances (CSBS), we extracted the naturally existing CSBS from urine from healthy individuals by conducting homogeneous crystallization of calcium oxalate. CSBS proved not to be promoters but rather strong inhibitors of calcium oxalate crystal growth and aggregation. It is suggested that CSBS exhibited their inhibitory effect by masking the growing sites and aggregating sites on the crystal surface. As for the characteristics of CSBS, we found around 10 peaks of molecular weight, and all of them contained both peptides and saccharides. The findings suggest that CSBS are composed of various kinds of glycoproteins and proteoglycans.
Similar articles
-
Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.Urol Res. 1993 May;21(3):187-92. doi: 10.1007/BF00590035. Urol Res. 1993. PMID: 8342253
-
An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine.Urol Res. 1990;18(6):373-9. doi: 10.1007/BF00297368. Urol Res. 1990. PMID: 2100411
-
Effects of urinary macromolecules on the crystallization of calcium oxalate.Urol Res. 1990;18(6):381-5. doi: 10.1007/BF00297369. Urol Res. 1990. PMID: 2100412
-
Glycoprotein calcium oxalate crystal growth inhibitor in urine.Miner Electrolyte Metab. 1987;13(4):267-72. Miner Electrolyte Metab. 1987. PMID: 3306319 Review.
-
Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation.World J Urol. 1997;15(3):155-64. doi: 10.1007/BF02201852. World J Urol. 1997. PMID: 9228722 Review. No abstract available.
Cited by
-
Characterization of protein components of human urinary crystal surface binding substance.Urol Res. 1997;25(5):355-60. doi: 10.1007/BF01294665. Urol Res. 1997. PMID: 9373917
-
Isolation and partial characterization of crystal matrix protein as a potent inhibitor of calcium oxalate crystal aggregation: evidence of activation peptide of human prothrombin.Urol Res. 1994;22(1):45-50. doi: 10.1007/BF00431548. Urol Res. 1994. PMID: 8073540
-
Calcium oxalate crystal matrix extract: the most potent macromolecular inhibitor of crystal growth and aggregation yet tested in undiluted human urine in vitro.Urol Res. 1995;23(1):53-62. doi: 10.1007/BF00298852. Urol Res. 1995. PMID: 7618236
-
Identification of a macromolecular crystal growth inhibitor in human urine as osteopontin.Urol Res. 1995;23(5):327-34. doi: 10.1007/BF00300022. Urol Res. 1995. PMID: 8839390
-
Heparin sulfate in the stone matrix and its inhibitory effect on calcium oxalate crystallization.Urol Res. 1993 May;21(3):187-92. doi: 10.1007/BF00590035. Urol Res. 1993. PMID: 8342253
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials